You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,062,264


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,062,264
Title:Fluid dispensing device
Abstract: A fluid dispensing device for dispensing a fluid product having a dispensing member mounted for movement along an axis X-X from a first position to a second position which causes a dose of a fluid product to be dispensed, and a finger-operable actuator member movable in an actuating direction generally transverse to the axis to cause at least one cam surface thereof to cam the dispensing member from the first position to the second position. The at least one cam surface has a commitment section, oriented at a first angle to the axis selected such that a minimum actuating force is required to be applied to the actuator member to cause the at least one cam follower surface to ride over the commitment section onto the drive section. The commitment section of the cam surface is arcuate.
Inventor(s): Godfrey; James William (Ware, GB), Hedley; Mark Graham (Ware, GB)
Assignee: Glaxo Group Limited (Greenford, Middlesex, GB)
Application Number:11/911,060
Patent Claim Types:
see list of patent claims
Device; Formulation;
Patent landscape, scope, and claims:

United States Patent 8,062,264: A Comprehensive Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 8,062,264, titled "Fluid dispensing device," is a significant patent that pertains to the design and functionality of a hand-held, manually operable intra-nasal fluid medicament dispenser. This article delves into the details of the patent's scope, claims, and the broader patent landscape surrounding this invention.

Background and Context

The patent, filed under the application number US11/911,060, was granted on November 22, 2011. It is part of a series of patents held by Haleon (formerly part of GlaxoSmithKline) related to nasal spray devices, particularly those used for medicaments like Flonase[4].

Scope of the Patent

General Description

The patent describes a fluid dispensing device designed for dispensing a fluid product, such as a medicament, specifically through an intra-nasal route. The device is hand-held and manually operable, making it user-friendly for administering doses of medication directly into the nasal cavity[1].

Key Components

  • Housing and Nozzle: The device features a plastics housing (e.g., ABS) with a nozzle at the upper end for insertion into the nasal cavity.
  • Fluid Discharge Device: This component is housed within the housing and is capable of reciprocal translation along its longitudinal axis.
  • Container and Pump: The fluid discharge device includes a container containing the medicament and a compression pump mounted on the container. The pump is actuated by moving the container upwardly in the housing[1].

Claims of the Patent

Independent Claims

The patent includes several independent claims that define the core aspects of the invention:

  • Claim 1: Describes the fluid dispensing device with a housing, a nozzle, and a fluid discharge device that includes a container and a pump.
  • Claim 10: Details the mechanism of actuation, including the use of finger-operable side levers that cam the container upwardly to compress the pump and dispense the medicament[1].

Dependent Claims

Dependent claims further elaborate on the specific features and functionalities:

  • Claim 2: Specifies the material of the housing (e.g., ABS).
  • Claim 3: Describes the nozzle's design for insertion into the nasal cavity.
  • Claim 4: Details the cam surfaces and cam follower surfaces that facilitate the actuation process[1].

Mechanism of Operation

Actuation Process

The device is actuated by moving a pair of opposed side levers inwardly with respect to the housing. This movement causes the container to be cammed upwardly, which in turn compresses the pump and dispenses a dose of the medicament through the nozzle[1].

Reset Mechanism

The pump is reset by its internal return spring after each actuation, allowing for repeated use until the container is empty[1].

Patent Landscape

Related Patents

The patent 8,062,264 is part of a broader portfolio of patents related to nasal spray devices held by Haleon. Other relevant patents include:

  • U.S. Pats. 8,147,461; 8,347,879; 8,752,543; 9,320,862; 10,391,717: These patents cover various aspects of nasal spray devices, including design improvements and additional functionalities[4].

Design Patents

In addition to utility patents, there are also design patents related to the aesthetic and functional design of the nasal spray devices, such as U.S. Design Pats. D775,945; D856,793; D818,818; D920,093[4].

Patent Analytics and Claim Coverage

Claim Coverage Matrix

To understand the full scope of protection provided by these patents, a Claim Coverage Matrix can be used. This matrix categorizes patents by claims and scope concepts, helping to identify gaps or opportunities in the patent landscape. For instance, Schwegman’s ClaimScape® software can generate interactive claim charts to review patent coverage and determine the applicability of scope concepts to target products or methods[5].

Scope Concepts

The scope concepts of the patent claims can be categorized into high, medium, or low value based on their current and future relevance to the company. This categorization helps in prioritizing patent maintenance and identifying future design opportunities[5].

Industry Impact and Market Dominance

Market Relevance

The invention described in U.S. Patent 8,062,264 has significant market relevance, particularly in the allergy relief and respiratory medication sectors. Products like Flonase, which utilize this technology, have become market leaders due to their ease of use and effectiveness[4].

Competitive Advantage

The robust patent portfolio surrounding this technology provides a competitive advantage to Haleon, protecting their intellectual property and preventing competitors from replicating similar designs and functionalities.

Key Takeaways

  • Intra-Nasal Dispensing Device: The patent describes a hand-held, manually operable device for dispensing medicaments intra-nasally.
  • Mechanism of Operation: The device uses finger-operable side levers to actuate a pump and dispense the medicament.
  • Related Patents: Part of a broader portfolio of patents related to nasal spray devices held by Haleon.
  • Patent Analytics: Utilizing tools like Claim Coverage Matrix and ClaimScape® software to analyze and manage patent claims.
  • Market Impact: Significant market relevance and competitive advantage in the allergy relief and respiratory medication sectors.

FAQs

Q1: What is the primary purpose of U.S. Patent 8,062,264?

The primary purpose of U.S. Patent 8,062,264 is to describe a hand-held, manually operable intra-nasal fluid medicament dispenser.

Q2: How does the device described in the patent dispense the medicament?

The device dispenses the medicament through the actuation of a pump by moving finger-operable side levers inwardly, which cams the container upwardly to compress the pump.

Q3: What is the role of the cam surfaces and cam follower surfaces in the device?

The cam surfaces and cam follower surfaces facilitate the actuation process by allowing the container to be moved upwardly when the side levers are operated.

Q4: How is the pump reset after each actuation?

The pump is reset by its internal return spring after each actuation.

Q5: What is the significance of the patent landscape surrounding this invention?

The patent landscape, including related utility and design patents, provides a robust protection of intellectual property and helps in maintaining a competitive advantage in the market.

Sources

  1. US8062264B2 - Fluid dispensing device - Google Patents
  2. United States Design Patent (12) - Googleapis.com
  3. Patent Claims Research Dataset - USPTO
  4. Flonase - Haleon Patent Information - Productpats
  5. Patent Analytics | Intellectual Property Law - SLWIP

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,062,264

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Haleon Us Holdings FLONASE SENSIMIST ALLERGY RELIEF fluticasone furoate SPRAY, METERED;NASAL 022051-002 Aug 2, 2016 OTC Yes Yes 8,062,264 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,062,264

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0507224.4Apr 09, 2005
PCT Information
PCT FiledApril 05, 2006PCT Application Number:PCT/GB2006/001264
PCT Publication Date:October 19, 2006PCT Publication Number: WO2006/109021

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.